TLP
Tri Locum Partners Portfolio holdings
AUM
$330M
This Quarter Return
+19.03%
1 Year Return
+35.44%
3 Year Return
+388.28%
5 Year Return
–
10 Year Return
–
AUM
$417M
AUM Growth
+$417M
(+5.5%)
Cap. Flow
-$9.03M
Cap. Flow
% of AUM
-2.16%
Top 10 Holdings %
Top 10 Hldgs %
79.89%
Holding
27
New
2
Increased
11
Reduced
6
Closed
7
Top Buys
| 1 |
Pfizer
PFE
|
$32.9M |
| 2 |
Stevanato
STVN
|
$26.1M |
| 3 |
Vaxcyte
PCVX
|
$18.1M |
| 4 |
VRNA
Verona Pharma
VRNA
|
$17.1M |
| 5 |
Natera
NTRA
|
$11M |
Top Sells
| 1 |
Ascendis Pharma
ASND
|
$31.1M |
| 2 |
Amgen
AMGN
|
$25.7M |
| 3 |
Axsome Therapeutics
AXSM
|
$19.3M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$18.4M |
| 5 |
Insmed
INSM
|
$12.6M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Regeneron Pharmaceuticals
REGN
$59.8B
| – | – |
-17,516
| Closed | -$18.4M |
|
27
Xenon Pharmaceuticals
XENE
$2.99B
| – | – |
-101,959
| Closed | -$3.98M |
|